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Abstract
Nanotechnology-based approaches offer the chemical control required to develop precision tools 
suitable for applications in neuroscience. We report a novel approach employing hybrid 
upconversion nanomaterials, combined with the photoresponsive ion channel channelrhodopsin-2 
(ChR2), to achieve near infrared light (NIR)-mediated optogenetic control of neuronal activity. 
Current optogenetic methodologies rely on using visible light (e.g. 470-nm blue light), which 
tends to exhibit high scattering and low tissue penetration, to activate ChR2. In contrast, our 
approach enables the use of 980-nm NIR light, which addresses the short-comings of visible light 
as an excitation source. This was facilitated by embedding upconversion nanomaterials, which can 
convert NIR light to blue luminescence, into polymeric scaffolds. These hybrid nanomaterial 
scaffolds allowed for NIR-mediated neuronal stimulation, with comparable efficiency as that of 
470-nm blue light. Our platform was optimized for NIR-mediated optogenetic control by 
balancing multiple physicochemical properties of the nanomaterial (e.g. size, morphology, 
structure, emission spectra, concentration), thus providing an early demonstration of rationally-
designing nanomaterial-based strategies for advanced neural applications.
GRAPHICAL ABSTRACT
Upconverting nanomaterial-based hybrid scaffolds were employed to optogenetically stimulate 
neurons with near-infrared light.
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The mammalian brain is a phenomenal piece of ‘organic machinery’, consisting of an 
intricate network of neurons dispersed in a mixture of chemical and biochemical 
constituents. While remarkable advances have been made to better understand the brain, the 
intrinsic complexity of the brain makes it difficult to probe the innate neuronal connectivity 
and to further modulate this activity. This is partly due to challenges in developing tools to 
effectively interact with the type of neurocircuitry found in the brain. Yet, given that the 
biomolecular interactions and chemical communication in the brain occur at the nanoscale, 
there is great interest in leveraging advances in nanotechnology for neuroscience research.1 
The reproducible control of chemical reactions and advanced nanoscience have enabled the 
generation of numerous types of nanomaterials and nanostructures with well-defined 
compositions, shapes and properties. This offers tremendous promise for creating a seamless 
integration of neural cells with synthetic materials, which can be further exploited to achieve 
improved control of neuronal activity and function. In this way, nanotechnology-based 
methods can be rationally-designed to interface with neural systems and to address prevalent 
challenges in neuroscience.
Herein, we demonstrate a unique application of inorganic-organic hybrid nanomaterials to 
the field of optogenetics. Optogenetics is a revolutionary technology that has transformed 
the field of neuroscience, allowing for the optical control of neuronal activity by using light 
(“opto”) and genetically-encoded photosensitive proteins (“genetics”).2, 3 In the last decade, 
optogenetic approaches have been successfully utilized to explore numerous neural states 
and disorders including fear, anxiety, addiction, reward-seeking behavior, autism and 
Parkinson’s disease.4 While it has facilitated novel investigations that were previously 
infeasible, the efficient optogenetic manipulation of neural activity is contingent on 
delivering a sufficient dose of light to the target neuronal cells.5 Visible light (~400–600 nm) 
has been primarily used in this regard to stimulate the photoresponsive opsin proteins (e.g. 
channelrhodopsins, ChR, that are activated by 470-nm blue light). A number of groups have 
also attempted to achieve optogenetic control using other wavelengths of illumination such 
as red-shifted light sources (>600 nm),6, 7 which can offer opportunities for multiplexed 
stimulation. The most common approach to implement this strategy has involved the 
combination of genome-wide screening and complex molecular engineering to generate new 
variants of microbial opsin that are sensitive to red light.8 However, such a strategy tends to 
require balancing numerous opsin-dependent design considerations including spectral 
specificity, optimal expression in target cells, efficient cellular trafficking to the plasma 
membrane and optimal kinetics/ion specificity.9 While valuable, developing optogenetic 
approaches employing highly red-shifted light has proven to be technically challenging.
In this work, we have developed an upconversion nanomaterial-based system to act as a 
mediator for facilitating optogenetic control using near-infrared (NIR) light (980 nm). 
Upconversion nanoparticles (UCNPs) have attracted significant biomedical interest due to 
their inherent ability to emit high-energy visible light upon excitation with low-energy NIR 
light.10 UCNPs possess a number of favorable characteristics compared to conventional 
fluorescent materials including high resistance to photoblinking and photobleaching, longer 
luminescence lifetimes and high signal-to-noise ratio due to weak background 
autofluorescence.11 Moreover, by carefully controlling the experimental conditions during 
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the synthesis process, the physicochemical properties of UCNPs (e.g. size, emission spectra, 
surface chemistry) can be finely-tuned based on the application of interest.12 So far, these 
features have made UCNPs particularly ideal for numerous bio-applications including 
cellular labeling, imaging and drug delivery.13–15 By generating a neural-material interface 
using UCNP-embedded polymer hybrid scaffolds, we provide one of the first 
demonstrations of upconversion nanomaterials as NIR-excitable internal light sources to 
achieve optogenetic control of mammalian neuronal activity (Fig. 1).
Acquiring optogenetic control of neurons relies on the exogenous expression of light-
sensitive ion channels within the neuronal plasma membrane.16 Channelrhodopsin-2 (ChR2) 
is one example of a microbial ion channel that conducts cation influx upon blue light 
illumination (~470–475 nm).17 The stable expression of ChR2 in mammalian neurons can 
thus render the neurons sensitive to activation with blue light.2 Given that the blue light-
responsive ChR2 is well-established and widely-used in optogenetics, we sought to design 
UCNPs that can activate ChR2 upon NIR illumination. The upconversion process (from NIR 
light to visible light) in UCNPs is permitted by the doping of trivalent lanthanide ions within 
a host matrix.10 Among other synthetic variables, selecting the proper lanthanide dopants is 
a critical factor that determines the wavelength-specific luminescence spectrum of the 
UCNP.18 To this end, a combination of the lanthanide ions Yb3+ (a sensitizer, which has an 
absorption cross-section in the NIR spectral region) and Tm3+ (an activator, which has 
optical emission in the blue spectral region) is reported to be a suitable pair to achieve blue 
emission (~475 nm).19, 20 We selected to employ Yb3+/Tm3+-doping for our study, since the 
resulting upconverted blue emission overlaps with the excitation spectra of ChR2,21 thus 
suggesting the possibility for UCNP-mediated optogenetic activation.
We sought to synthesize monodispersed UCNPs that exhibit strong upconversion 
luminescence under NIR illumination. To this end, we synthesized β-hexagonal-phase 
UCNPs consisting of a sodium yttrium fluoride (NaYF4) host matrix co-doped with 
Yb3+/Tm3+ using a co-precipitation method from a previous report.22 With modifications to 
the experimental conditions and further optimization, we synthesized NaYF4: Yb3+/Tm3+ 
UCNPs with 30 mol% Yb3+ and 0.2 mol% Tm3+. Transmission electron microscopy (TEM) 
shows a spherical morphology of the particles, with an average diameter of 36.2 ± 1.5 nm 
(Fig. 2a). In order to preserve the optical integrity of the nanoparticles, we further coated the 
nanoparticles with an inert thin-shell of NaYF4. This is reported to be an important step 
because lanthanide dopants exposed on the nanoparticle surface can undergo deactivation 
due to surface defects, lattice strains and interactions with the surrounding solvents.23, 24 An 
inert shell can thus minimize surface quenching-induced emission loss and preserve high 
UCNP luminescence.25 The epitaxial growth of a NaYF4 shell was carried on the UCNP 
cores as reported previously.24 TEM confirmed the shell formation and the monodisperity of 
the resulting core-shell UCNPs, which displayed an average diameter of 46.7 ± 2.4 nm (Fig. 
2a). The core-shell UCNPs exhibited an absorption peak at 980 nm (Fig. S1 in ESI) and 
peak emission in the blue spectral region at ~475 nm upon excitation with 980-nm NIR light 
(Fig. 2b–c). Powder X-ray diffraction (PXRD) patterns exhibit peak positions and intensities 
that can be indexed with the β-hexagonal phase NaYF4 crystal structure,26 further 
confirming the high crystallinity of the UCNPs (Fig. 2d). The quantum yield of our core-
shell UCNPs is expected to be ~1–3%, based on previous reports.27, 28
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With the as-synthesized core-shell UCNPs exhibiting favorable spectral properties for ChR2 
activation, we next encapsulated the particles within a biomaterial scaffold. Biomaterials are 
becoming increasingly useful for neural engineering since they can be tailored to interact 
with nervous tissue on a molecular, cellular and tissue level.29 At the same time, 
biomaterials can serve as reliable scaffolds to load and immobilize cells, biomolecules and 
other materials over long periods of time. To this end, compared to a solution-based delivery 
of UCNPs that can suffer from diffusion of particles over time and high variability in particle 
distribution, we elected to embed the UCNPs within a biomaterial scaffold for our studies. 
We used poly(lactic-co-glycolic acid) (PLGA) as the underlying biomaterial scaffold, since 
it is biocompatible, biodegradable, FDA-approved and widely-used for in vivo 
transplantation in the nervous system.30, 31 In order to acquire a uniform nanoparticle 
distribution within the polymer matrix, UCNPs from a stock solution were first mixed with 
the PLGA solution. After thorough mixing to disperse the UCNPs, the PLGA-UCNP 
solution was spin-coated to form thin films on circular glass coverslips (Fig. 3a). A number 
of parameters were optimized including the amount of UCNP loading, percentage of PLGA 
and speed of spin-coating (see Supporting Information for details). Flexible thin films (~0.5 
μm thickness) of PLGA-UCNP were generated that could be peeled from the glass coverslip 
(Fig. 3b). Moreover, the hybrid scaffolds showed blue luminescence under NIR irradiation, 
owing to the distribution of UCNPs throughout the polymer film (Fig. 3b). This 
luminescence spectra of the hybrid scaffold was evaluated using fluorescence emission 
spectroscopy (Fig. S2 in ESI), which confirmed the optical integrity and presence of UCNPs 
within the polymer films. Increasing the power of NIR illumination was further observed to 
exponentially increase blue light emission from the scaffolds, exhibiting a linear relationship 
on a double logarithmic scale (Fig. S3 in ESI). Further varying the initial amount of UCNPs 
mixed with the PLGA solution (prior to spin-coating) enabled the generation of films with 
varying concentrations of embedded UCNPs (quantification shown in Table S1), which were 
characterized using scanning electron microscopy (SEM) (Fig. S4 in ESI) and atomic force 
microscopy (AFM) (Fig. S5 in ESI). By tuning both the concentration of UCNPs embedded 
within the film and the power of NIR illumination, a range of blue emission output can be 
achieved (Fig. S6 in ESI).
The polymer-UCNP hybrid scaffolds were then utilized to achieve optical activation of 
cultured neurons expressing ChR2. Mouse hippocampal neurons were isolated from 
postnatal day 0 (P0) mice pups and plated on the hybrid scaffold surface pre-coated with 
Matrigel. Thereafter, the neuronal cultures were transduced with ChR2-tdTomato via 
lentiviruses after 4–5 days in vitro (DIV) growth. The neurons attached and showed complex 
morphology with extensive dendritic branching by 14 DIV (Fig. S7 in ESI). Cell viability 
assay further confirmed that the hybrid scaffold did not have any adverse effects on neuronal 
survival (Fig. S8 in ESI). SEM images display neurons cultured on the polymer scaffold 
with uniformly distributed UCNPs, thus allowing high localization of UCNPs in close 
cellular proximity (Fig. 3c).
At 14–15 DIV, we conducted whole-cell patch clamping experiments to measure the light-
mediated neuronal response. The whole-cell patch clamp technique is a method to record the 
ionic current flow across the neuronal membrane, as well as changes in the membrane 
potential, in response to an applied stimuli (e.g. light).32 Since ChR2 is a light-gated cation 
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channel, the opening of this channel upon light illumination would facilitate the influx of 
cations and lead to an inward current flow to drive neuronal depolarization.2, 17 The 
membrane-localized expression of ChR2 was first confirmed by the presence of tdTomato 
fluorescence using confocal microscopy (Fig. 4a). Not surprisingly, the inward current 
response could be induced in these cells when light-emitting diode (LED)-generated 470-nm 
light was supplied via the microscope objectives (Fig. 4b). We then delivered 980-nm NIR 
light using an external optical cable setup (Fig. S9 in ESI). Remarkably, an inward current 
response was immediately evident upon NIR light illumination, similar as that observed by 
using the conventional 470-nm light (Fig. 4b).
While the presence of an inward current flow is an indicator of successful UCNP-mediated 
optogenetic control, the generation of nerve impulses (i.e. action potentials) would provide 
stronger and more reliable functional evidence for our approach. Nerve impulses mediate the 
information flow in the nervous system, and can only be generated by a sufficient increase 
(i.e. depolarization) in the membrane potential past a predefined threshold.33 Given that the 
time course of upconversion in UCNPs is less than half a millisecond (Fig. S10 in ESI), we 
were able to apply low NIR pulse widths that are generally used for optogenetic studies. In 
our studies, we checked for nerve impulse generation by applying brief pulses (3 ms pulse 
duration) of light to neurons under current-clamp recording mode. Remarkably, nerve 
impulses elicited with 980-nm NIR illumination were comparable to those elicited with 470-
nm light (Fig. 4c), indicating a sufficient blue luminescence from the UCNPs to activate 
ChR2 and drive neuronal depolarization beyond the nerve impulse firing threshold. 
Moreover, 980-nm illumination of the ChR2-expressing neurons cultured on the hybrid 
scaffolds enabled the generation of time-locked, sustained naturalistic trains of impulses 
with millisecond-timescale temporal resolution, in response to light pulses delivered at 1 Hz, 
5 Hz and 10 Hz (Fig. 4d). Impulses were generated with frequencies up to 20 Hz using NIR 
light (Fig. S11 in ESI). This is in contrast to 980-nm illumination of control substrates, i.e. 
ChR2-infected neurons on PLGA substrates (Fig. S12 in ESI) and non-infected neurons on 
PLGA-UCNP substrates (Fig. S13 in ESI), which showed negligible membrane 
depolarization and a lack of nerve impulse generation. This indicates the inability of 980-nm 
NIR light alone to activate ChR2-expressing neurons. The membrane depolarization and the 
reliable generation of action potentials described above was obtained for polymer films 
containing a minimal UCNP concentration of 8.3 μg/mm2, wherein lower concentrations did 
not generate action potentials.
The physicochemical properties of the upconversion nanomaterial can play a significant role 
in determining the overall effectiveness of our approach. For instance, we had initially 
considered employing upconversion nanomaterials in the form of nanorods, due to closer 
resemblance to bulk materials.18 These upconversion nanorods (UCNRs) were synthesized 
as reported previously,18 using the Yb3+/Tm3+ dopants to achieve a blue luminescence 
spectra similar to the core-shell UCNPs shown in Figure 2 (Fig. S14 in ESI). These rod-
shaped particles, with a length of about 200 nm and width of 50 nm, were embedded within 
PLGA films and cultured with neurons (Fig. S15 in ESI). However, the whole-cell patch 
clamping experiments showed inconsistent and unreliable nerve impulse generation, 
especially at higher frequency pulses (Fig. S16 in ESI). In addition, nerve impulse 
generation with the UCNR-based hybrid scaffolds required higher NIR power (2 W) and 
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longer NIR pulse durations (50 ms) compared to the core-shell UCNP-based hybrid 
scaffolds (1 W, 3 ms). In fact, core-shell UCNP-based hybrid scaffolds enabled successful 
generation of action potentials at longer NIR pulse duration as well, in the form of sustained 
spikelets (Fig. S17 in ESI). The ineffectiveness of UCNRs can be attributed to multiple 
factors, including non-uniformity and random orientation after film formation (Fig. S18 in 
ESI), as well as surface-quenching effects from the lack of an inert shell (complete shell 
formation on UCNRs is a technical challenge due to highly anisotropic particle growth34). 
Besides, the larger size and rod-like morphology of UCNRs makes them less favorable when 
considering future applications for in vivo studies.35 In this way, the design and systematic 
testing of nanomaterials is invaluable for evaluating their prospects in neural applications 
such as optogenetics.
In summary, we have developed a novel and promising proof-of-concept/method as a 
complementary technique to expand the optogenetic toolbox. Our approach is unique in that 
we employ UCNPs as mediators to convert NIR light into opsin-activating visible light. 
From an application perspective, UCNPs can be excited with relatively inexpensive 
continuous wave (CW) diode lasers; this is in stark contrast to two-photon approaches, 
which require high-energy femtosecond pulsed lasers and instrumentation for raster 
scanning of a focused beam over the region of interest.36 Moreover, while conventional 
approaches focus on engineering new opsin-variants to impart red-shifted spectral 
sensitivity,37, 38 our approach entailed synthetically-tuning UCNPs to emit at a specific 
wavelength of light (e.g. 475 nm blue light) upon NIR excitation to activate ChR2. In this 
way, our current in vitro approach can be useful to assess the UCNP-mediated stimulation of 
a variety of different opsins, which exhibit peak sensitivity to different wavelengths of light 
(e.g. green, yellow) and can be excitatory or inhibitory.9 In other words, a library of 
combinatorial UCNPs can be systematically designed and easily tested for stimulating a 
corresponding library of well-established opsins. This offers an additional wavelength for 
optogenetic control, which can facilitate multiplexed stimulation and spatiotemporally 
confine emission to regions containing UCNPs. Such a level of control can help explore 
specific biological questions at the single-cell level on these unique neural-material 
interfaces, which are not only biocompatible but also provide a biologically-relevant 
functionality. With rising interest in improving control over neuronal activity and function, 
creating effective interfaces between neurons and external materials will be invaluable. 
Overall, the integration of chemical control and nanotechnology with optogenetics holds 
great potential for advancing applications in neuroscience research.
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Figure 1. Schematic diagram depicting the generation and application of polymer-UCNP hybrid 
scaffolds for optogenetic neuronal activation
Upconversion nanoparticles (UCNPs) were embedded within polymeric films to form 
biocompatible hybrid scaffolds for neuronal culture. The UCNPs served as internally 
excitable light sources that convert NIR light into blue light, thus facilitating optogenetic 
activation of channelrhodopsin (ChR)-expressing neurons.
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Figure 2. Monodisperse core-shell UCNPs with blue emission upon near-infrared excitation were 
synthesized
(a) Transmission electron microscopy (TEM) image of core NaYF4:Yb3+/Tm3+ (30 / 0.2 
mol%) nanoparticles (left, scale bar: 100 nm) and core@shell NaYF4:Yb3+/Tm3+ (30 / 0.2 
mol%)@NaYF4 UCNPs (right, scale bar: 50 nm). (b) Photographic image of a cuvette with 
a suspension of UCNPs under laser excitation at 980-nm. (c) Upconversion emission 
spectrum of core-shell UCNPs in hexane solution (1 mg/mL) under near-infrared light 
excitation at 980-nm. (d) Powder X-ray diffraction (PXRD) patterns of the core-shell 
UCNPs, showing all peaks to be well-indexed in accordance with the β-hexagonal-phase 
NaYF4 crystal structure (Joint Committee on Powder Diffraction Standards file No. 
16-0334).
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Figure 3. Blue-emitting UCNPs were embedded within thin polymer films of PLGA and cultured 
with hippocampal neurons
(a) Schematic depicting preparation of poly(lactic-co-glycolic acid) (PLGA)-embedded 
UCNP hybrid scaffolds for hippocampal neuronal cultures. (b) Photographic image of the 
flexible hybrid scaffold film. The blue luminescence under 980-nm laser excitation 
illustrates the encapsulation of UCNPs throughout the PLGA film. Scanning electron 
microscopy (SEM) image shows the distribution of the UCNPs within the PLGA film. Scale 
bar: 500 nm (bottom), 100 nm (inset). (c) Scanning electron microscopy (SEM) image of a 
hippocampal neuron (pseudo-colored red for contrast) cultured on the polymer-UCNP 
hybrid scaffolds at 14 DIV. Scale bar: 5 μm (left), 200 nm (right).
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Figure 4. Channelrhodopsin-expressing neurons grown on polymer-UCNP films exhibit robust 
excitatory activation upon NIR-light illumination, comparable to blue LED illumination
(a) Hippocampal neurons expressing ChR2-tdTomato (red). Scale bar: 50 μm. (b) 
Representative traces of inward current flow in voltage-clamped neuron evoked by 470-nm 
light (5 mW) and 980-nm light (1 W). (c) Magnified action potential induced by 470-nm 
light (top) and 980-nm light (bottom). (d) Representative traces showing repetitive action 
potentials in a current-clamped hippocampal neuron evoked by 1 Hz, 5 Hz and 10 Hz train 
of light pulses from 470-nm light (top; 250 mW, 3 ms pulse width) and 980-nm light 
(bottom; 1 W, 3 ms pulse width).
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